Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
BJTJ-00012 by Beijing Tuojie Biomedical Technology for Unspecified Metabolic Disorders: Likelihood of Approval
BJTJ-00012 is under clinical development by Beijing Tuojie Biomedical Technology and currently in Phase II for Unspecified Metabolic Disorders. According...